CChubb Read More Chubb (CB) Q1 2026 Earnings Call Transcript2026-04-22 ]]> Image source: The Motley Fool. DATE Wednesday, April 22, 2026 at 8:30 a.m. ET CALL PARTICIPANTSChairman &…
UUBS Read More TSLA’s 5-Day Win Streak: AI5 Chip, Terafab & UBS Boost – Is it a Buy?2026-04-16 Shares of TeslaTSLA climbed above their 50-day moving average in the previous session, marking the fifth straight day…
UUBS Read More TSLA’s 5-Day Win Streak: AI5 Chip, Terafab & UBS Boost – Is it a Buy?2026-04-16 Shares of TeslaTSLA climbed above their 50-day moving average in the previous session, marking the fifth straight day…
UUBS Read More Nvidia Could Be the First $22 Trillion Stock, According to 1 Top Analyst. But There’s a Big Catch.2026-04-14 Key Points UBS’ HOLT model estimates Nvidia’s valuation at $22 trillion based on its cash flow return on…
UUBS Read More Why Micron Technology Stock Is Climbing Higher Today2026-04-08 It’s not only the generally positive sentiment that’s sweeping through markets today that’s contributing to the rise in…
UUBS Read More UBS Stock Rallies 6.5% on Signal of Softer Swiss Capital Requirements2026-04-01 Shares of UBS Group AG UBS rose nearly 6.5% yesterday following reports that Swiss lawmakers are likely to…
RRoche Read More Roche Boosts AI Infrastructure with Additional Nvidia Chips, Stock Rises2026-03-18 Swiss pharma giant Roche (RHHBY) announced that it is expanding its AI (artificial intelligence) infrastructure by deploying an…
RRoche Read More Roche’s Genentech Expands Investment in North Carolina Facility to $2B2026-03-18 Swiss pharma giant Roche’s RHHBY Genentech announced a significant expansion of its original investment in a new manufacturing…
CChubb Read More Chubb’s Solid Growth Comes With a Premium Valuation – Hold or Buy?2026-03-14 Chubb LimitedCB is a leading global property and casualty insurer and reinsurer with a diversified portfolio spanning commercial…
RRoche Read More Roche Advances Obesity Pipeline as Petrelintide Meets Phase II Goal2026-03-12 Roche RHHBY has announced that the mid-stage study ZUPREME-1, evaluating the investigational candidate petrelintide for the treatment of…
RRoche Read More Roche Advances Obesity Pipeline as Petrelintide Meets Phase II Goal2026-03-11 Roche RHHBY has announced that the mid-stage study ZUPREME-1, evaluating the investigational candidate petrelintide for the treatment of…
GGlencore Read More Discovery Announces Acquisition of Glencore’s Kidd Operations2026-03-02 Supports Discovery’s vision to more than double gold production in Timmins to over half a million ounces per…